HETEROZYGOSITY FOR AN EXON-12 SPLICING MUTATION AND A W234G MISSENSE MUTATION IN AN AMERICAN CHILD WITH CHRONIC TYROSINEMIA TYPE-1

被引:8
作者
HAHN, SH
KRASNEWICH, D
BRANTLY, M
KVITTINGEN, EA
GAHL, WA
机构
[1] NICHHD,HUMAN GENET BRANCH,HUMAN BIOCHEM GENET SECT,BETHESDA,MD 20892
[2] UNIV OSLO,INST CLIN BIOCHEM,OSLO,NORWAY
关键词
TYROSINEMIA; FUMARYLACETOACETATE HYDROLASE; SPLICING; MISSENSE; TRANSFECTION;
D O I
10.1002/humu.1380060113
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Hereditary tyrosinemia type 1, an autosomal recessive disorder caused by deficiency of fumarylacetoacetate hydrolase (FAH), manifests in either an acute or a chronic form, We used reverse transcription and the polymerase chain reaction to amplify the FAH cDNA of a 12-year-old American boy with chronic tyrosinemia type 1. The patient is a compound heterozygote for mutations in the FAH gene. One allele contains a missense mutation in codon 234 changing a tryptophan to a glycine; this allele was of maternal origin. Mutagenesis and transfection into COS cells demonstrated that the W234G mutation abolishes FAH activity. The patient's paternally derived allele is a splicing mutation in the + 5 position of intron 12, causing either insertion of a 105 bp fragment due to a cryptic splice site, or skipping of exon 12, or skipping of both exons 12 and 13. The chronic phenotype of tyrosinemia type 1 in this patient may be due to some residual, correct splicing by the allele with the splicing mutation. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:66 / 73
页数:8
相关论文
共 26 条
[1]   NUCLEOTIDE-SEQUENCE OF CDNA-ENCODING HUMAN FUMARYLACETOACETASE [J].
AGSTERIBBE, E ;
VANFAASSEN, H ;
HARTOG, MV ;
REVERSMA, T ;
TAANMAN, JW ;
PANNEKOEK, H ;
EVERS, RF ;
WELLING, GM ;
BERGER, R .
NUCLEIC ACIDS RESEARCH, 1990, 18 (07) :1887-1887
[2]  
ARREDONDOVEGA FX, 1994, AM J HUM GENET, V54, P820
[3]  
Ausubel FM, 1987, CURRENT PROTOCOLS MO
[4]  
DEBRAEKELEER M, 1990, AM J HUM GENET, V47, P302
[5]  
GOLDSMITH LA, 1989, METABOLIC BASIS INHE, P547
[6]   MUTATIONS OF THE FUMARYLACETOACETATE HYDROLASE GENE IN 4 PATIENTS WITH TYROSINEMIA, TYPE-I [J].
GROMPE, M ;
ALDHALIMY, M .
HUMAN MUTATION, 1993, 2 (02) :85-93
[7]  
GROMPE M, 1994, PEDIATR RES, V35, P895
[8]   MURINE FUMARYLACETOACETATE HYDROLASE (FAH) GENE IS DISRUPTED BY A NEONATALLY LETHAL ALBINO DELETION THAT DEFINES THE HEPATOCYTE-SPECIFIC DEVELOPMENTAL REGULATION-1 (HSDR-1) LOCUS [J].
KLEBIG, ML ;
RUSSELL, LB ;
RINCHIK, EM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (04) :1363-1367
[9]   DEFICIENT FUMARYLACETOACETATE FUMARYLHYDROLASE ACTIVITY IN LYMPHOCYTES AND FIBROBLASTS FROM PATIENTS WITH HEREDITARY TYROSINEMIA [J].
KVITTINGEN, EA ;
HALVORSEN, S ;
JELLUM, E .
PEDIATRIC RESEARCH, 1983, 17 (07) :541-544
[10]   HEREDITARY TYROSINEMIA TYPE-I - SELF-INDUCED CORRECTION OF THE FUMARYLACETOACETASE DEFECT [J].
KVITTINGEN, EA ;
ROOTWELT, H ;
BRANDTZAEG, P ;
BERGAN, A ;
BERGER, R .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) :1816-1821